Spring Loaded Tri-Compartment Unloader Knee Brace Study

May 1, 2026 updated by: Seth Sherman, Stanford University

Examining the Efficacy of a Tri-Compartment Unloader Knee Brace During Physical Rehabilitation in Non-Surgical Patients With Anterior Knee Pain

This study will examine clinical outcomes related to pain and function in patients with anterior knee pain (i.e. focal patella and/or trochlea cartilage defect(s), patellofemoral arthritis) before and after standard of care, non-surgical management with and without the addition of a Tri-Compartment Unloader (TCU) knee brace during activities of daily living. Randomly selected participants will wear a TCU brace for several weeks during physical therapy and activities of daily living that is designed to reduce compressive forces in all three compartments of the knee during weight-bearing flexion. Our hypothesis is that TCU bracing will improve clinical outcomes related to pain and function.

Study Overview

Status

Completed

Conditions

Detailed Description

Patients in this study have been identified as good candidates by their physicians. As the study procedures closely follow the standard of care procedures in place, study participation presents little additional risk above and beyond the standard of care procedures. The study was designed to present the least risk possible consistent with sound research design.

Participants in this study will undergo standard of care X-rays that will help in eligibility determination. Participants will be randomized to either group, and will have a 50% chance of receiving the brace. Outcomes will be measured at baseline (before any intervention), 6 weeks after commencing rehabilitation at Stanford, and 3 months after commencing rehabilitation at Stanford.

These outcome measures are collected using PatientiQ which is is being used at the clinic as part of standard of care. Spring Loaded Tech is providing the TCU braces for the patients in this study at no cost.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Redwood City, California, United States, 94063
        • Stanford Redwood City Outpatient Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Anterior knee pain that worsens when the knee is flexed and bearing weight
  2. Patellofemoral chondral defect(s) or patellofemoral arthritis detected with standard of care x-ray and/or MRI
  3. Kellgren and Lawrence grade 0-3 of PF joint
  4. Able to wear the TCU knee brace for a minimum of 3 hours per day
  5. Over 18 years old, can understand written English
  6. Coronal knee alignment within 7 degrees of neutral
  7. Must be able to fit within an off-the-shelf knee brace size provided by Company
  8. Must complete physical therapy through Stanford

Exclusion Criteria:

  1. Surgical intervention definitely indicated (major mechanical symptoms/failed substantial previous conservative measures) on the affected knee within the next year
  2. Use of another brace designed to unload the knee or manage knee pain during the study
  3. Varus/Valgus joint alignment > 7 degrees
  4. Inability to be fit properly in an off-the-shelf brace provided by the Company
  5. BMI >40
  6. Bilateral knee symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: No Brace Group
50% of the participants in the study that will not be receiving a TCU brace.
Experimental: Tri-Compartment Unloader Brace Group
50% of the participants in the study that will be receiving a TCU brace.
Knee brace that is designed to reduce compressive forces on all three compartments of the knee.
Other Names:
  • TCU Brace

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: Baseline, 6-weeks, and 3-months
Knee Injury and Osteoarthritis Outcome Score (KOOS) patient-reported outcome questionnaire; responses are scaled to a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.
Baseline, 6-weeks, and 3-months
Pain Visual Analog Scale (VAS)
Time Frame: Baseline, 6-weeks, and 3-months
Visual Analog Scale (VAS) is rated on a scale of 0 to 100 where 0 means no pain and 100 means severe pain.
Baseline, 6-weeks, and 3-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life (EQ-5D)
Time Frame: Baseline, 6-weeks, and 3-months
Quality of life (EQ-5D) has 5 response levels where level 1 equates to no problems and level 5 equates to severe problems. The EQ-5D assesses quality of life across five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The responses are then scaled to a score of 0 to 100 (high scores correspond to higher health related quality of life).
Baseline, 6-weeks, and 3-months
Lower Extremity Activity Scale (LEAS)
Time Frame: Baseline, 6-weeks, and 3-months
Lower Extremity Activity Scale (LEAS) measures daily physical activity by having patients answer 20 questions, choosing from 18 options of activity levels (0 = no activity, to 18 = college/professional athlete level of activity). Individual scores are summed and averaged to create the overall score (range: 0 to 18, with highest scores corresponding to highest level of activity).
Baseline, 6-weeks, and 3-months
Quadricep Strength (Girth)
Time Frame: Baseline through 3-months post-intervention
Using a biodex to measure quadriceps strength. Number of participants achieving a minimal clinically important difference (MCID) in quadriceps strength, defined as a greater than or equal to 10% increase from baseline.
Baseline through 3-months post-intervention
Effusion Grade
Time Frame: Baseline through 3-months post-intervention
Number of participants with effusion, by grade. Checking how much fluid is around the knee. There are different grades, ranging from Grade 1 to Grade 5. Grade 1 means no fluid-wave while performing a downward stroke whereas Grade 5 means excess of fluid that makes it impossible to stroke the medial fluid away.
Baseline through 3-months post-intervention
Painful Crepitus With Deep Knee Flexion
Time Frame: Baseline through 3 months post-intervention
Number of participants with painful crepitus at deep knee flexion, which is when there is a sensation or noise when you move a joint.
Baseline through 3 months post-intervention
Knee Range of Motion
Time Frame: Baseline through 3 months post-intervention
Number of participants with full or deficient range of motion (ROM). Knee range of motion is measured at 0º extension (completely straight leg) to 130º, a fully flexed leg. Deficient ROM is nonzero at full extension and/or < 130° flexion. Full ROM is defined as 0° extension and 130° flexion.
Baseline through 3 months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Seth L Sherman, MD, Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 5, 2022

Primary Completion (Actual)

November 5, 2024

Study Completion (Actual)

November 5, 2024

Study Registration Dates

First Submitted

June 16, 2022

First Submitted That Met QC Criteria

June 16, 2022

First Posted (Actual)

June 23, 2022

Study Record Updates

Last Update Posted (Actual)

May 5, 2026

Last Update Submitted That Met QC Criteria

May 1, 2026

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 62059

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to share data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Knee Pain

Clinical Trials on Tri-Compartment Unloader Brace

Subscribe